Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187


Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.

Wendt MK, Tian M, Schiemann WP.

Cell Tissue Res. 2012 Jan;347(1):85-101. doi: 10.1007/s00441-011-1199-1. Epub 2011 Jun 21. Review.


The relevance of the TGF-β Paradox to EMT-MET programs.

Morrison CD, Parvani JG, Schiemann WP.

Cancer Lett. 2013 Nov 28;341(1):30-40. doi: 10.1016/j.canlet.2013.02.048. Epub 2013 Mar 5. Review.


TGF-β signaling and epithelial-mesenchymal transition in cancer progression.

Katsuno Y, Lamouille S, Derynck R.

Curr Opin Oncol. 2013 Jan;25(1):76-84. doi: 10.1097/CCO.0b013e32835b6371. Review.


The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Taylor MA, Parvani JG, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15. Review.


Noncanonical TGF-β signaling during mammary tumorigenesis.

Parvani JG, Taylor MA, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46. doi: 10.1007/s10911-011-9207-3. Epub 2011 Mar 31. Review.


Tumor-promoting functions of transforming growth factor-β in progression of cancer.

Miyazono K, Ehata S, Koinuma D.

Ups J Med Sci. 2012 May;117(2):143-52. doi: 10.3109/03009734.2011.638729. Epub 2011 Nov 24. Review.


[The role of TGF-β-related signal transduction pathways in pathogenesis of epithelial-mesenchymal transition as a key element in cancer development and progression].

Pieniążek M, Donizy P, Ziętek M, Szynglarewicz B, Matkowski R.

Postepy Hig Med Dosw (Online). 2012 Sep 7;66:583-91. Review. Polish.


Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.

Yang H, Zhan L, Yang T, Wang L, Li C, Zhao J, Lei Z, Li X, Zhang HT.

Oncol Rep. 2015 Jul;34(1):87-94. doi: 10.3892/or.2015.3961. Epub 2015 May 7.


MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.


Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.

Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.

Cancer Res. 2008 Mar 1;68(5):1388-97. doi: 10.1158/0008-5472.CAN-07-2706.


Autocrine PDGFR signaling promotes mammary cancer metastasis.

Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H, Grünert S.

J Clin Invest. 2006 Jun;116(6):1561-70.


Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.

Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, Aakre M, Pickup MW, Gorska AE, Zijlstra A, Moses HL.

Breast Cancer Res. 2012 Jul 2;14(4):R98. doi: 10.1186/bcr3217.


Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.

Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M, Wang XJ.

J Clin Invest. 2005 Jul;115(7):1714-23. Epub 2005 Jun 2.


TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells.

Kawata M, Koinuma D, Ogami T, Umezawa K, Iwata C, Watabe T, Miyazono K.

J Biochem. 2012 Feb;151(2):205-16. doi: 10.1093/jb/mvr136. Epub 2011 Dec 7.


Induction of epithelial-mesenchymal transition by transforming growth factor β.

Moustakas A, Heldin CH.

Semin Cancer Biol. 2012 Oct;22(5-6):446-54. doi: 10.1016/j.semcancer.2012.04.002. Epub 2012 Apr 23. Review.


TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.

Räsänen K, Vaheri A.

J Dermatol Sci. 2010 May;58(2):97-104. doi: 10.1016/j.jdermsci.2010.03.002. Epub 2010 Mar 17.


Supplemental Content

Support Center